Sun Pharma Advanced Research Company Ltd share price logo

Sun Pharma Share Price

NSE: SPARC

BSE: 532872

Small Cap

Healthcare Sector

₹124.94

-4.61

(-3.56%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Sun Pharma Stock Performance

as on January 23, 2026 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹123.25
    ₹130.31
    downward going graph

    1.35%

    Downside

    4.30%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹109.30
    ₹204.40
    downward going graph

    12.52%

    Downside

    63.60%

    Upside

    downward going graph

Sun Pharma share price movements today

Previous Close
₹129.55
Open
₹129.40
Volume
4.79L
Upper Circuit
₹155.46
Lower Circuit
₹103.64
Day's Low - High
₹123.25 - ₹130.31
52 Week Low - High
₹109.30 - ₹204.40

Sun Pharma Historical Returns

1 Month Return
-7.87 %
3 Month Return
-4.89 %
1 Year Return
-26.91 %
3 Year Return
-37.59 %
5 Year Return
-32.15 %

Sun Pharma Fundamentals

as on January 23, 2026 at 4:01 pm IST

Market Cap

₹4,054.57 Cr

Return on Equity (ROE)

0

PE Ratio (TTM)

-15.18

Return on capital employed (ROCE)

0

Industry PE ratio

40.46

Beta (LTM)

1.4

P/B Ratio

-21.76

Dividend Yield

0

PEG Ratio

-3.47

Quarterly Earnings Growth YOY

-29.33

EPS (TTM)

-10.55

Sector

Pharmaceuticals

Book Value

-6.68

Technical Analysis

Bearish

View Technical Analysis

Sun Pharma Stock Valuation

as on January 23, 2026 at 4:01 pm IST

Sun Pharma in the last 5 years

  • Overview

  • Trends

Lowest (-38.16x)

April 8, 2024

Today (-15.18x)

January 23, 2026

Industry (40.46x)

January 23, 2026

Highest (0.00x)

December 29, 2023

LowHigh

Today’s Price to Earnings Ratio: -15.18x

Sun Pharma Advanced Research Company Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sun Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Sun Pharma Advanced Research Company Ltd image
Sun Pharma Advanced Research Company Ltd
BUY4,054.57-6.43%1.88-34371
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
BUY14,598.76-3.79%0.682641,197
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY15,230.674.81%0.718367,234
Rainbow Childrens Medicare Ltd image
Rainbow Childrens Medicare Ltd
BUY12,040.8532.67%0.672441,515
Poly Medicure Ltd image
Poly Medicure Ltd
BUY16,116.1640.82%0.533381,669
See all

Analyst Recommendation on Sun Pharma Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Sun Pharma. Average target price of ₹2000

Source: S&P Global Market Intelligence

Sun Pharma Share Price Target

Get share price movements and forecasts by analysts on Sun Pharma.

What analysts predicted

1500.77%UPSIDE

Target Price

₹2000

Current Price

₹124.94

Analyzed by

1 Analysts

High

₹2000

Target

₹2000.00

Low

₹2000

Sun Pharma target price ₹2000, a slight upside of 1500.77% compared to current price of ₹124.94. According to 1 analysts rating.

Source: S&P Global Market Intelligence

Sun Pharma Stock’s Investor Sentiment and Interest

Search interest for Sun Pharma Advanced Research Company Ltd Stock has decreased by -66% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-66% versus previous 30 day period

Sun Pharma Advanced Research Company Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
47.69
23.95
21.18
13.86
16.56
16.81
12.86
14.91
27.19
9.64
7.86
Other Income
10.73
10.19
8.49
6.39
4.4
1.56
0.04
0.19
-
9.14
0.01
Total Income
58.42
34.14
29.67
20.25
20.96
18.37
12.9
15.1
27.19
18.78
7.87
Expenses
137.26
126.13
112.65
116.48
122.39
110.17
115.77
88.6
80.37
61.72
73.58
Operating Profit
-89.57
-102.18
-91.47
-102.62
-105.83
-93.36
-102.91
-73.69
-53.18
-52.08
-65.72
Operating Profit Margin %
-187.82%
-426.64%
-431.87%
-740.4%
-639.07%
-555.38%
-800.23%
-494.23%
-195.59%
-540.25%
-836.13%
Profit Before Interest, Tax and Depreciation
-78.84
-91.99
-82.98
-96.23
-101.43
-91.8
-102.87
-73.5
-53.18
-42.94
-65.71
Interest
0.21
0.26
0.26
0.26
0.91
0.56
1.14
2.8
4.54
6.19
7.52
Depreciation
2.94
3.1
3.18
3.16
3.07
3.14
3.16
3.14
2.95
2.68
2.56
Profit Before Tax
-81.99
-95.35
-86.42
-99.65
-105.41
-95.5
-107.17
-79.44
-60.67
-51.81
-75.79
Tax Paid
-
-
-
-
0.38
0.4
0.16
0.07
-0.9
0.06
0.06
Profit After Tax
-81.99
-95.35
-86.42
-99.65
-105.79
-95.9
-107.33
-79.51
-59.77
-51.87
-75.85
Total Net profit including share of profit / Loss from associate company
-81.99
-95.35
-86.42
-99.65
-105.79
-95.9
-107.33
-79.51
-59.77
-51.87
-75.85
EPS
-2.55
-2.94
-2.66
-3.07
-3.26
-2.96
-3.31
-2.45
-1.84
-1.6
-2.34
Actual EPS
-2.55
-2.94
-2.66
-3.07
-3.26
-2.96
-3.31
-2.45
-1.84
-1.6
-2.34
Adjusted EPS
-2.55
-2.94
-2.66
-3.07
-3.26
-2.96
-3.31
-2.45
-1.84
-1.6
-2.34
Diluted EPS
-2.55
-2.94
-2.66
-3.07
-3.26
-2.96
-3.31
-2.45
-1.84
-1.6
-2.34

Sun Pharma Advanced Research Company Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2023
Mar 2024
Mar 2025
Sales
238.78
75.55
71.77
Other Income
10.88
29.47
1.79
Total Income
249.66
105.02
73.56
Expenses
452.84
477.65
394.91
Operating Profit
-214.06
-402.1
-323.14
Operating Profit Margin %
-89.65%
-532.23%
-450.24%
Profit Before Interest, Tax and Depreciation
-203.18
-372.63
-321.35
Interest
7.63
1.69
9.04
Depreciation
11.77
12.51
12.39
Profit Before Tax
-222.58
-386.83
-342.78
Tax Paid
-
0.38
-0.27
Profit After Tax
-222.58
-387.21
-342.51
Total Net profit including share of profit / Loss from associate company
-222.58
-387.21
-342.51
EPS
-7.82
-11.93
-10.55
Actual EPS
-7.82
-11.93
-10.55
Adjusted EPS
-7.82
-11.93
-10.55
Diluted EPS
-7.82
-11.93
-10.55

Sun Pharma Advanced Research Company Ltd Cash Flow

Figures in Rupees Crores

Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
-69.12
-429.19
-360.29
Cash Flow from Investing Activities
-548.28
391.53
157.67
Cash Flow from Financing Activities
616.75
42.41
199.25
Net Cash Flow
-0.64
4.75
-3.37

Sun Pharma Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
65.67%
65.67%
65.67%
65.67%
65.67%
65.67%
65.67%
65.67%
65.67%
65.67%
65.67%
65.67%
DII
0.78%
0.78%
0.23%
0.81%
0.82%
0.18%
0.23%
0.64%
1.13%
0.97%
1.05%
0.78%
FII
0%
0%
0%
3.3%
3.23%
2.64%
2.15%
2.23%
1.45%
1.47%
1.76%
2.04%
Public
29.91%
29.91%
29.86%
30.21%
30.28%
31.51%
31.95%
31.46%
31.75%
31.88%
31.52%
31.5%
Total Outstanding Shares
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
Total Shareholders
98,777
1,00,807
1,01,433
1,03,990
1,02,743
1,25,184
1,28,205
1,31,034
1,42,864
1,40,724
1,36,997
1,44,810

Sun Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Sun Pharma.

  • Sun Pharma Advanced Research Company Ltd Earnings Results

    Sun Pharma Advanced Research Company Ltd’s net profit jumped 29.33% since last year same period to ₹-75.85Cr in the Q2 2025-2026. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated -46.23% fall in its net profits since last 3-months.

    Read More about Earnings Results

Indices Featuring Sun Pharma Stock

Check stock indices that include Sun Pharma.

BSE Healthcare

₹41,313.49

-1.21 (▲504.50%)

BSE Small-Cap

₹46,825.31

-2.19 (▲1050.74%)

Insights on Sun Pharma Advanced Research Company Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 0.94% to 1.01% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 1.47% to 1.76% in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 21.1% return, outperforming this stock by 48.0%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 65.67% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 148.1% return, outperforming this stock by 185.7%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 31.88% to 31.52% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, SPARC stock has moved down by -37.6%

About Sun Pharma Advanced Research Company Ltd

Sun Pharma Advanced Research Company Ltd (“SPARC”) is a clinical stage biopharmaceutical company focused on innovation and new product development for global markets. Established in 2006, it is engaged in the creation of new drugs and delivery systems, undertaking projects in research and technology for new chemical entities (“NCEs”) and novel drug delivery systems (“NDDS”). SPARC operates in global markets including the US, India and China. It has successfully received approvals from the US FDA for various drugs such as ELEPSIA XR Levetiracetam extended-release tablets 1000 mg and 1500 mg, XELPROS Latanoprost BAKfree eyedrops and for XELPROS latanoprost ophthalmic emulsion 0.005 which was inlicensed from Sun Pharma in 2015. In 2021, it commenced the commercialization of ElepsiaTM XR to Visiox Pharma, with eligible milestone payments and royalties and acquired exclusive rights for antibody against a unique oncology target from Biomodifying. SPARC is focused on advancement of clinical trials with vodobatinib being granted orphan drug designation for the treatment of CML and it has completed phase I study of SCD044.

Revenue: ₹7.86Cr as on September 2025 (Q2 FY26)
Net Profit: ₹-75.85Cr as on September 2025 (Q2 FY26)
Listing date: 18 Jul, 2007
Chairperson Name: Dilip S Shanghvi
OrganisationSun Pharma Advanced Research Company Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEODilip S Shanghvi
E-voting on sharesClick here to vote

FAQs

What is Sun Pharma share price today?

Sun Pharma share price today stands at ₹124.94 as on at the close of the market. Sun Pharma share today touched a day high of ₹130.31 and a low of ₹123.25.

What is the 52 week high and 52 week low range for Sun Pharma share?

Sun Pharma touched a 52 week high of ₹204.4 and a 52 week low of ₹109.3. Sun Pharma share price today i.e. is closed at ₹124.94, which is -38.87% down from its 52 week high and 14.31% up from its 52 week low.

What is Sun Pharma's market capitalisation today?

Sun Pharma market capitalisation is ₹4,054.57 Cr as on .

How to buy Sun Pharma shares?

To buy Sun Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SPARC or Sun Pharma Advanced Research Company Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Sun Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Sun Pharma trading volume today?

Sun Pharma trading volume is 4.79L as on . This means that 4.79L shares of Sun Pharma were bought and sold on the stock market during today's trading session.